Melissa Krauth

2.3k total citations · 2 hit papers
8 papers, 1.8k citations indexed

About

Melissa Krauth is a scholar working on Nephrology, Pharmacology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Melissa Krauth has authored 8 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Nephrology, 3 papers in Pharmacology and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Melissa Krauth's work include Pharmacology and Obesity Treatment (3 papers), Advanced Glycation End Products research (2 papers) and Eicosanoids and Hypertension Pharmacology (2 papers). Melissa Krauth is often cited by papers focused on Pharmacology and Obesity Treatment (3 papers), Advanced Glycation End Products research (2 papers) and Eicosanoids and Hypertension Pharmacology (2 papers). Melissa Krauth collaborates with scholars based in United States, Denmark and United Kingdom. Melissa Krauth's co-authors include Colin J. Meyer, Robert D. Toto, Paul Audhya, Heidi Christ‐Schmidt, Janet Wittes, Pablo E. Pérgola, Jesse W. Huff, Stacey Ruiz, Philip Raskin and Eric Grossman and has published in prestigious journals such as New England Journal of Medicine, Nephrology Dialysis Transplantation and Molecular Cancer Therapeutics.

In The Last Decade

Melissa Krauth

8 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease

2013 784 citations Dick de Zeeuw, Tadao Akizawa et al. New England Journal of Medicine profile →
Bardoxolone Methyl and Kidney Function in CKD with Type 2 Diabetes

2011 707 citations Pablo E. Pérgola, Philip Raskin et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Melissa Krauth

Since Specialization

Citations

This map shows the geographic impact of Melissa Krauth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melissa Krauth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melissa Krauth more than expected).

Fields of papers citing papers by Melissa Krauth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melissa Krauth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melissa Krauth. The network helps show where Melissa Krauth may publish in the future.

Co-authorship network of co-authors of Melissa Krauth

This figure shows the co-authorship network connecting the top 25 collaborators of Melissa Krauth. A scholar is included among the top collaborators of Melissa Krauth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melissa Krauth. Melissa Krauth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

#	Work	Indexed citations
1	Peloruside A Inhibits Growth of Human Lung and Breast Tumor Xenografts in an Athymic nu/nu Mouse Model 2015 ·Molecular Cancer Therapeutics ·Colin J. Meyer, Melissa Krauth, Michael J. Wick, Jerry W. Shay, Ginelle C. Gellert, Jef K. De Brabander, Peter T. Northcote, John H. Miller	19
2	Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease breakdown → 2013 ·New England Journal of Medicine ·Dick de Zeeuw, Tadao Akizawa, Paul Audhya, George L. Bakris, Melanie Chin, Heidi Christ‐Schmidt, Angie Goldsberry, Mark T. Houser, Melissa Krauth, Hiddo J.L. Heerspink, John J.V. McMurray, Colin J. Meyer, Hans‐Henrik Parving, Giuseppe Remuzzi, Robert D. Toto, Nosratola D. Vaziri, Christoph Wanner, Janet Wittes, (unknown), Glenn M. Chertow	784
3	Rationale and Trial Design of Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes: The Occurrence of Renal Events (BEACON) 2013 ·American Journal of Nephrology ·Dick de Zeeuw, Tadao Akizawa, Rajiv Agarwal, Paul Audhya, George L. Bakris, Melanie Chin, Melissa Krauth, Hiddo J.L. Heerspink, Colin J. Meyer, John J.V. McMurray, Hans‐Henrik Parving, Pablo E. Pérgola, Giuseppe Remuzzi, Robert D. Toto, Nosratola D. Vaziri, Christoph Wanner, David G. Warnock, Janet Wittes, Glenn M. Chertow	75
4	Baseline characteristics in the Bardoxolone methyl EvAluation in patients with Chronic kidney disease and type 2 diabetes mellitus: the Occurrence of renal eveNts (BEACON) trial 2013 ·Nephrology Dialysis Transplantation ·Hiddo J.L. Heerspink, Glenn M. Chertow, Tadao Akizawa, Paul Audhya, George L. Bakris, Angie Goldsberry, Melissa Krauth, Peter G. Linde, John J.V. McMurray, Colin J. Meyer, Hans‐Henrik Parving, Giuseppe Remuzzi, Heidi Christ‐Schmidt, Robert D. Toto, N. D. Vaziri, Christoph Wanner, Janet Wittes, (unknown), Dick de Zeeuw	20
5	Effect of Bardoxolone Methyl on Kidney Function in Patients with T2D and Stage 3b–4 CKD 2011 ·American Journal of Nephrology ·Pablo E. Pérgola, Melissa Krauth, Jesse W. Huff, Deborah A. Ferguson, Stacey Ruiz, Colin J. Meyer, David G. Warnock	197
6	Bardoxolone Methyl and Kidney Function in CKD with Type 2 Diabetes breakdown → 2011 ·New England Journal of Medicine ·Pablo E. Pérgola, Philip Raskin, Robert D. Toto, Colin J. Meyer, Jesse W. Huff, Eric Grossman, Melissa Krauth, Stacey Ruiz, Paul Audhya, Heidi Christ‐Schmidt, Janet Wittes, David G. Warnock	707
7	639 POSTER RTA 301 (peloruside): a novel microtubule stabilizer with potent in vivo activity against lung cancer and resistant breast cancer 2006 ·European Journal of Cancer Supplements ·Craig S. Meyer, David Ferguson, Melissa Krauth, (unknown), Peter T. Northcote	12
8	CHANGES IN INSULIN RECEPTOR CONCENTRATION IN RAT FAT CELLS FOLLOWING TREATMENT WITH THE GESTAGENS CLOMEGESTONE ACETATE AND CYPROTERONE ACETATE 1977 ·European Journal of Endocrinology ·Melissa Krauth, E. Schillinger	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact